Pfizer Commercial Oncology is seeking a Senior Director, Team Lead to lead the US breast cancer CDK4/6 portfolio, encompassing IBRANCE and the planned successor atirmociclib. The role owns the IBRANCE P&L and atirmociclib pre-launch investment plan, including forecasting, operating expenses, resource allocation, revenue and expense trade-offs associated with loss of exclusivity, and deliberate redeployment of released resources to portfolio priorities. The position reports to the VP, US Breast Cancer Franchise Lead and leads 6–8 HCP and patient marketers at Director and Senior Manager levels. The leader will set a multi-year strategy for the transition from IBRANCE to atirmociclib: maximizing IBRANCE value through the PATINA launch, heritage campaign, IRA changes and LOE, while building atirmociclib’s market, evidence base, launch readiness and organization. This includes strategic and tactical leadership across HCP, account, patient, advocacy, market access, pricing, trade, sales, analytics and cross-functional stakeholder engagement. The role is a member of the BC franchise leadership team and the broader Oncology Business extended leadership team.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior